[AsCNP_P16] ポスター16
Neurological Disorders

[AsCNP-P16-2] KCC2, a K⁺-Cl^- co-transporter, is a possible target to attenuate the neuronal dysfunction that is associated with radiation therapy for brain tumor

^○Kento IGARASHI^{1, 2}, Kazuo TOMITA^{1, 2}, Koh-ichi TANAKA^{1, 2}, Yoshikazu KUWAHARA^{1, 3}, Nobuyoshi NISHIYAMA², Akihiro KURIMASA³, Tomoaki SATO¹ (1. Lab. of applied phapharmacology, Graduate school of medical and dental sciences, Kagoshima University, Kagoshima, Japan, 2. Department of Pharmacy, School of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan, 3. Department of Radiation Biology and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan)